New pill shows promise against tough cancers in early trial
NCT ID NCT04045496
First seen Dec 29, 2025 · Last updated May 21, 2026 · Updated 15 times
Summary
This early-phase study tested a new daily pill called JAB-3312 in 40 adults with advanced solid tumors (like lung, colorectal, or breast cancer) that had stopped responding to standard treatments. The main goals were to find the safest dose and check for side effects. Researchers also looked for signs that the drug could shrink tumors, but this is a first step to see if the drug is safe enough for larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
HealthONE Clinic Services Oncology-Hematology
Denver, Colorado, 80202, United States
-
Tennessee Oncology, PLLC
Nashville, Tennessee, 37203, United States
-
The University of Texas M. D. Anderson Cancer Center
Houston, Texas, 77030, United States
-
Washington University School of Medicine
Seattle, Washington, 63110, United States
Conditions
Explore the condition pages connected to this study.